Since NHEJ, MMEJ and HR pathways all operate in S and G2 phases, the repair of a DSB by a particular pathway is not determined simply by limiting the availability of specific repair factors to defined phases of the cell cycle. We reasoned that this choice is more likely established by proteins that function in the initial steps of DSB repair, involving the recognition and processing of DNA ends. Moreover, that a potential candidate for this role is CtIP, which is known to promote resection of DNA ends to the single-stranded DNA (ssDNA) tails that are essential for HR[@R5],[@R6].

Analysis of CtIP in mammalian cells is difficult as homozygous deletion of *CtIP* in mice results in early embryonic lethality[@R7]. To circumvent this problem we generated *ctip* null mutant cells from the avian B cell line DT40. In DT40 *CtIP* is present in three copies due to a chromosomal duplication of chromosome 2[@R8]. We disrupted all three *CtIP* alleles, deleting exons 1 and 2, containing the initiation codon and 5′ untranscribed region of the gene, and replaced them with antibiotic resistance cassettes ([Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). We confirmed the generation of *ctip* (-/-/-) mutant cells by Southern blot and the loss of CtIP protein expression by Western blot ([Supplementary Fig. 2b,c](#SD1){ref-type="supplementary-material"}).

In common with other DNA repair-defective mutants[@R9],[@R10]​, *ctip* cells exhibit reduced proliferation rate, compared with wild-type cells ([Supplementary Fig. 3a](#SD1){ref-type="supplementary-material"}). Moreover, in clonogenic survival assays they are highly sensitive to X-rays, which cause DSBs ([Fig. 1a](#F1){ref-type="fig"}). They are also sensitive to cisplatin (CDDP), which generates interstrand DNA crosslinks that may also lead to the generation of DSB during replication ([Fig. 1a](#F1){ref-type="fig"}). In contrast, *ctip* cells are not very sensitive to UV light, which causes pyrimidine dimers and 6-4 photoproducts[@R11] ([Fig. 1a](#F1){ref-type="fig"}). Importantly, expression of human CtIP (*Hs*CtIP) in *ctip* mutant cells fully restored the resistance of these cells to X-rays, confirming that the human and avian CtIP proteins are functionally conserved ([Fig. 1a](#F1){ref-type="fig"}, [Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}).

It was reported that CtIP promotes resistance to DSB-inducing agents exclusively during S and G2 phases[@R5],[@R12]. Accordingly, *ctip* cells isolated by elutriation in S/G2 phase ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}), are 5- to 6-fold more sensitive to X-ray damage (LD~10~ = 2.5 Gy) than are wild-type cells and approximately 2-fold more sensitive than NHEJ-defective *ku70* mutant cells ([Fig. 2a](#F2){ref-type="fig"}, upper panel). Surprisingly, *ctip* cells isolated in G1 phase are also sensitive to X-ray-induced DNA damage (LD~10~ = 2.2 Gy) ([Fig. 2a](#F2){ref-type="fig"}, lower panel), suggesting that CtIP function is not limited to S/G2 phase, as previously proposed, but contributes to the repair of DSB throughout the cell cycle. And, since HR does not function in G1 phase, CtIP must be involved in a second pathway for repairing DSBs.

The fact that CtIP is required for repair of X-ray-induced DSBs in G1 and S/G2 phases raised the possibility that it functions commonly in both HR and DNA end-joining. To address this we made use of several GFP-reporter assays that measure the repair of a restriction enzyme-induced DSB by different repair pathways ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}).

For HR we measured the repair of a defined I-*Sce*I-induced genomic DSB in a defective GFP reporter gene (Sce-GFP^[@R13]^) ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). In line with previous studies[@R7] we observed a 10-fold defect in HR for *ctip* mutant cells compared to wild-type cells ([Fig. 3a](#F3){ref-type="fig"}). A second form of homology directed DNA repair is single-strand annealing (SSA). This occurs when a DSB is generated between two directly repeated sequences and is achieved by resection of DNA ends to produce homologous ssDNA tails that can anneal to promote joining[@R14]. Again we found that *ctip* mutant cells are 10-fold defective in SSA compared with wild-type cells ([Fig. 3b](#F3){ref-type="fig"}). We conclude that CtIP plays an important role in DSB repair by HR and this accounts for the sensitivity of *ctip* cells to X-ray damage in S and G2 phases.

DNA end-joining is achieved either through NHEJ, whereby broken DNA ends are directly rejoined, or by MMEJ in which DNA ends are resected locally to reveal short regions of complementary DNA (4 to 6 nucleotides) which stabilise broken ends for ligation[@R1]. We tested *ctip* cells for both types of end-joining and found no defect in accurate NHEJ ([Fig. 3c](#F3){ref-type="fig"}). In fact we observed a slight increase in NHEJ activity in the *ctip* mutant compared with wild-type cells. On the other hand, for MMEJ we observed a 4- to 5-fold defect in the *ctip* mutant compared with wild-type cells ([Fig. 3d](#F3){ref-type="fig"}).

In a second assay we transfected cells with linearised plasmid, recovered the repaired plasmids after 24 hours and examined the DNA sequences surrounding the joints ([Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). Both wild-type and *ctip* mutant cells repaired the majority of breaks through a combination of accurate and inaccurate NHEJ ([Fig 3e](#F3){ref-type="fig"}). Where NHEJ was inaccurate, the spectrum of deletions at the break site was similar in *ctip* and wild-type cells. Nevertheless, in the *ctip* mutant cells we again detected a reduction in MMEJ ([Fig. 3e](#F3){ref-type="fig"}). Together, with observations in 293 cells that siRNA-mediated knockdown of CtIP alters the balance of DSB repair[@R15], these data establish a role for CtIP in MMEJ and provide an explanation for the defects in DSB repair observed in *ctip* cells during G1 phase.

A role for CtIP in DSB repair during G1 was unexpected. Previous studies suggested that CtIP is present at very low levels outside of the S and G2 phases[@R12],[@R16]. Nevertheless, CtIP was present in extracts from DT40 cells in G1 albeit at reduced levels compared to cells in S/G2 ([Fig. 2b](#F2){ref-type="fig"}). Furthermore, whereas in G1 phase CtIP is largely unmodified, the majority of CtIP in S/G2 is phosphorylated ([Fig. 2b](#F2){ref-type="fig"}).

Previously Yu and Chen demonstrated that CtIP is phosphorylated on serine residue 327 as cells enter S phase, which mediates its interaction with the tumour suppressor BRCA1 that is required for the transient G2/M checkpoint[@R12],[@R17]. Therefore, we next considered whether phosphorylation of serine 327 might also regulate the function of CtIP in DSB repair. To investigate this we expressed a mutant form of *Hs*CtIP, in which serine 327 was substituted by alanine (*Hs*CtIP^S327A^), in *ctip* cells and examined its sensitivity to X-rays. While expression of *Hs*CtIP^S327A^ improved the survival of *ctip* cells to X-rays, complementation was only partial ([Fig.1a](#F1){ref-type="fig"}), suggesting that mutation of serine 327 results in loss of some but not all the repair functions of CtIP.

The picture became clearer when we looked at the survival to X-ray damage in different phases of the cell cycle. We found that expression of either *Hs*CtIP or *Hs*CtIP^S327A^ in *ctip* cells fully restored resistance to X-rays in G1 phase and restored MMEJ to wild-type levels in a plasmid assay ([Fig 3d](#F3){ref-type="fig"}), suggesting that phosphorylation on serine 327 is not required for the repair of DSB by MMEJ ([Fig 2a](#F2){ref-type="fig"}). However, expression of *Hs*CtIP^S327A^ in *ctip* cells did not restore HR, suggesting that phosphorylation of serine 327 is important for this function ([Fig. 3a,b](#F3){ref-type="fig"}). Accordingly, the sensitivity *ctip* cells to X-rays in S/G2, was only partially restored by *Hs*CtIP^S327A^ ([Fig. 2a](#F2){ref-type="fig"}), which can be accounted for by restoration of MMEJ, but not HR, in these cells.

How might phosphorylation of serine 327 on CtIP increase the contribution of HR during S phase? It is known that CtIP promotes the resection of DNA ends[@R5] and that this is an important step in both HR and MMEJ. However, since MMEJ requires small local regions of microhomology it is likely that the resection required for this pathway is less extensive than for strand exchange in HR. We reasoned, therefore, that phosphorylation of CtIP might upregulate the generation of ssDNA.

To test this we took advantage of the fact that BrdU incorporated into the genome is detectable by anti-BrdU antibody only in regions of ssDNA[@R18]. We cultured cells in BrdU, treated them with X-rays and stained for BrdU at intervals up to 2 hours ([Fig. 4a](#F4){ref-type="fig"}). Approximately 25% of unirradiated cells exhibit 10 or more BrdU foci. After exposure to X-rays (8 Gy) we observed a time-dependent increase in BrdU staining in wild-type cells until, after 2 hours, approximately 50% contained 10 or more BrdU foci. Over the same time period only 30% of *ctip* mutant cells stained with BrdU, suggesting that while these mutant cells are not completely defective in the generation of ssDNA after exposure to X-rays, it occurs more slowly. Moreover, expression of *Hs*CtIP in the *ctip* fully rescued this delay. On the other hand, expression of *Hs*CtIP^S327A^ cells did not complement this defect in the *ctip* mutant, suggesting that DNA damage-dependent increase in ssDNA is linked to the phosphorylation of serine 327. The delayed generation of ssDNA is not linked to reduced growth rate as cells expressing *Hs*CtIP^S327A^ exhibit reduced BrdU foci but proliferate normally ([Supplementary Fig. 7](#SD1){ref-type="supplementary-material"}).

Our data place CtIP at the 'crossroads' between DNA end-joining and HR pathways for the repair of DSB, with phosphorylation of serine 327 acting as a cell-cycle dependent switch that regulates CtIP-dependent DNA end resection. Phosphorylation of serine 327 is known to control the interaction of CtIP with BRCA1 in DT40[@R12] ([Supplementary Fig. 8a](#SD1){ref-type="supplementary-material"}). Moreover, like serine 327 of CtIP, BRCA1 is required for repair of DSB by HR but not MMEJ ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Fig. 8b](#SD1){ref-type="supplementary-material"}), suggesting that the recruitment of BRCA1 to CtIP may be a determining factor in this switch.

Serine 327 lies within a weak CDK consensus site (SP/TP) in CtIP which, combined with the presence of a cyclin interaction motif (ZRXL)[@R19], makes it a likely substrate for cyclin-dependent kinases. This residue is specific to CtIP in higher eukaryotes and is not present in Sae2, the CtIP---like protein of the budding yeast, *S. cerevisiae*. In yeast, HR and DNA end resection are promoted by CDK-dependent phosphorylation of Sae2 on serine 267[@R20],[@R21]. Interestingly, this site is conserved at threonine residue 847 of vertebrate CtIP[@R21], which we show here performs a similar function to S267 of Sae2 (Supplementary Figs [9](#SD1){ref-type="supplementary-material"} and [10](#SD1){ref-type="supplementary-material"}). In CtIP, substitution of T847 to alanine causes defects in the repair of DSB by HR in S phase, but does not affect MMEJ. Accordingly, cells expressing CtIP^T847A^ exhibit increased mutagenic repair of DSB ([Supplementary Fig. 10d](#SD1){ref-type="supplementary-material"}). Moreover, as in yeast, the requirement for phosphorylation of T847 can be circumvented by the use of a phosphomimic mutation where T847 in CtIP is replaced by aspartate or glutamate (CTIP^PM^). This mutant exhibits normal resection and restoration of HR without phosphorylation at T847 (Supplementary Figs [10](#SD1){ref-type="supplementary-material"} and [11](#SD1){ref-type="supplementary-material"}).

While in yeast the switch to accurate DSB repair in S phase is controlled by phosphorylation of a single CDK site in Sae2, our data demonstrate that phosphorylation of CtIP at two independent CDK sites (S327 and T847) is required in vertebrates. The particular importance of S327 and the requirement of BRCA1 for this switch were established in two ways. Firstly, while expression of CtIP^PM^ restores HR to *ctip* mutant cells without the requirement for phosphorylation at residue 847, we found that the CtIP^S327A,PM^ mutant, in which phosphorylation at S327 is not possible, is defective in HR ([Supplementary Fig. 10e](#SD1){ref-type="supplementary-material"}). Secondly, we show that a CtIP^PM^ mutant does not restore HR to *brca1* mutant cells, confirming that recruitment of BRCA1 by CtIP is required for efficient HR function independently from the activation at T847 ([Fig 4c](#F4){ref-type="fig"}).

Together these data establish a pivotal role for CtIP and BRCA1 in a switch that has profound consequences for the maintenance of genetic integrity in DNA-damaged cells by facilitating a shift from predominantly error-prone repair of DSB by DNA end-joining in G1 to the accurate repair afforded by HR in S and G2 phases.

Methods Summary {#S1}
===============

DT40 chicken cells were propagated in standard RPMI supplemented media[@R11] at 37 °C, 6% CO~2~. Transfections were carried out by electroporation as previously described[@R11]. For the generation of CtIP knockout cells genomic DNA sequences were amplified with LA-TaKara and targeting vectors assembled (neomycin, histidinol and blasticidin). For each transfection, 30 μg of the selected vector were linearized using *Not*I (NEB) and transfected into DT40 cells. Clones were obtained after 2-4 weeks of growth under selective media. Genomic DNA from individual clones was prepared with PURAGENE DNA Purification Kit (Gentra). Twenty μl of each were digested with *Pac*I and *Xmn*I (NEB) at 37 °C overnight, and used in Southern blotting to detect targeted integration. Membranes were hybridized with a ^32^P GgCtIP probe ([Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}). Primers used for generating targeting vectors are listed in Supplementary Methods. Expression vectors for complementation studies were generated by insertion of CtIP cDNA into pCR2.1-TOPO and subsequent subcloning into pcDNA3.1/zeo(+). Primers used for cloning CtIP are listed in Supplementary Methods. Clonogenic survival assays were performed as previously described[@R11]. Cells were isolated at specific stages of the cell cycle by elutriation. Briefly, 10^9^ DT40 cells were collected by centrifugation, resuspended in 20 ml RPMI medium and drawn into a standard (4 ml) chamber at 4000 rpm in a Beckman JE-5.0 centrifugal elutriation rotor. Cells were maintained at a constant flow rate (38 ml/min) and were elutriated by decreasing the rotor speed at intervals of 250 rpm. For each elutriation interval, a 150 ml fraction was collected and cells spun down, resuspended in 3 ml cold PBS and counted. An aliquot of 1×10^5^ cells was incubated for 10 minutes with 1 μl of the cell-permeable DNA dye Draq5 (Biostatus Ltd) and the cell cycle profile determined by FACS analysis on a FACScan cytometer (Becton Dickinson).
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Full Methods {#S3}
============

Primers {#S4}
-------

### GgCtIP knock out {#S5}

For the construction of the targeting vectors the following primers were used:

Left arm :

5′SalI-CtIP L arm: 5′-gtcgacCAGAATCCCTCAGGTCCTGGAATG-3′

3′BglII-CtIP L arm: 5′-agatctATTTGTGGTCTGCTGGCTGTTGGG-3′

Right arm:

5′BglII-CtIP R arm: 5′-agatctTGACCATTTTGGTCCAGTTAAATC-3′

3′NotI-CtIP R arm: 5′-gcggccgcGCACTCTATTGGAGGTATTGCC-3′

For the screening of clones by Southern blot, a probe was designed with the following primers:

Probe forward: 5′-CCTGATGAATGTCTACTGTGGTGCATTCTT-3′

Probe reverse: 5′-CGCCTTTAATAAGTTAGATCATCAGTATGA -3′

### pCMV/cyto/GFP\* primers {#S6}

EJfwd: 5\_-CTAGGGATAACAGGGTAATCGGCTAG-3\_

EJrev: 5\_-CCATTACCCTGTTATCCCTAGCTAG-3\_

### CtIP cloning primers {#S7}

5′BamHI CtIP (pcDNA3.1): 5′-ggatccaccATGAACATCTTGGGAAGCAGCTGTG-3′

3′NotI CtIP (pcDNA3.1): 5′-gcggccgcCTATGTCTTCTGCTCCTTGCCT-3′

### CtIP mutagenesis CtIPS327A {#S8}

Forward primer: 5′-CCTACTCGAGTGTCAGCTCCTGTATTTGGAG-3′

Reverse primer: 5′-CTCCAAATACAGGAGCTGACACTCGAGTAGG-3′

Inmunoprecipitation and Western Blotting {#S9}
----------------------------------------

Whole cell extracts were prepared from 15×10^6^ chicken DT40 cells lysed in NET-N buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.1% NP-40) supplemented with protease and phosphatase inhibitors (1 mM NaF, 1 mM Na~3~VO~4~ and 10 mM β---glycerophosphate). Nuclear extracts were prepared as previously described.

For immunoprecipitation analysis, nuclear or whole cell extract were incubated with 30-10μl of the indicated antibodies and 40 μl of protein A/G-sepharose beads (Amersham). Beads were collected by centrifugation, washed 5 times with 1 ml NET-N buffer and boiled for 5 minutes in 50 μl of 2X SDS loading buffer (0.1 mM Tris-HCl pH 6.8, 4% SDS, 20% glycerol, 0.1% β-mercaptoethanol, 0.004% bromophenol blue). Twenty μl of each sample were resolved by SDS-PAGE. Proteins were identified by standard Western blot using the following primary antibodies: CtIP (T-16) sc-5970 (Santa Cruz Inc.) 1:500 dilution, GgBRCA1 (non commercial) 1:1000 dilution. Proteins were visualized using ECL-plus (Amersham).

Cell cycle analysis {#S10}
-------------------

Cells were pulsed with 20 μM BrdU (Sigma) for 20 min, washed them twice with PBS and fixed them overnight in 70% ethanol at -20 °C. Cells were stained against BrdU and propidium iodide and cell cycle analysis performed as described[@R10].

HR and SSA assays {#S11}
-----------------

For the HR assay, DT40 cells stably expressing a single copy of DR-GFP (M. Jasin, Sloan-Kettering) were a gift from J. Di Noia (Université de Montréal). For the SSA assay, the vector pHPRT-SSA-GFP (M. Jasin, Sloan-Kettering) was stably transfected into DT40 or *ctip* mutant cells. The clones obtained after puromicin selection were screened for single integrants by Southern blotting. To perform each of the experiments, cells were transfected with either pCASce[@R13] or the control plasmid pDsRed1-N1 (Clontech) using the Amaxa Nucleofection system. They were then suspended in 5 ml of medium, incubated at 37 °C for 24 h and washed in 500 μl of PBS. Eight μg ml^-1^ propidium iodide was added to the samples transfected with pCASce. Cells expressing GFP were quantified using a FACScan cytometer (Becton Dickinson). Data are corrected for transfection efficiency as measured by the percentage of cells that express DsRed.

MMEJ and EJ assays {#S12}
------------------

For the MMEJ assay, the vector pCMV/cyto/myc/GFP (Invitrogen) was modified by insertion of a pre-annealed oligo (EJfwd and EJrev) carrying an I-*Sce*I restriction site into the unique *Bmt*I site present in the GFP coding sequence, to generate pCMV/cyto/myc/GFP\*. The vector was digested with I-*Sce*I at 37 °C overnight, analyzed for complete digestion and ethanol precipitated. Ten μg of either uncut pCMV/cyto/myc/GFP (transfection control) or I-*Sce*I-digested pCMV/cyto/myc/GFP\* were used for transient transfection of DT40 cells with the Amaxa Nucleofection system and analysed as described above. The same protocol was used for the EJ assay but transfections were carried out with *Hinc*II-digested pCMV/cyto/myc/GFP or its uncut version. For the analysis of joined DSBs, cells were transfected with a I-*Sce*I linearized vector pCMV/cyto/myc/GFP\* as described. Plasmid DNA was extracted and used to tranform DH5 alpha bacteria. Resistant colonies were grown in 96-well agar plates and sequence analysis performed using a pCMV-F primer (GATC biotech).

DT40 Immunofluorescence {#S13}
-----------------------

DT40 cells were cultured for one and a half cell cycles in the presence of bromodeoxyuridine (BrdU, 20 μM, Invitrogen). After this period, cells were grown in 6-well-plates at 3×10^6^ cells per well and exposed to X-rays as described above. Glass coverslips coated with poly-L-lysine (Sigma) were added to each sample. At different times after irradiation, cells were washed with PBS, fixed in 4% paraformaldehyde for 5 min and washed with PBS a second time. Cells subject to denaturing conditions were treated for 30 min with 2 ml of 2 N HCl/0.5% triton X-100 and neutralized with 2 ml Na tetraborate, after which they were blocked in PBSTS/1% BSA alongside cells subject to native conditions. Samples were next incubated with mouse polyclonal antibody against BrdU (BD Pharmigen) for 2 h. Coverslips were washed 2X with PBSTS/1% BSA, incubated with an antibody against mouse Ig FITC-conjugated (BD Pharmigen) for 1 h, washed twice in PBS and finally mounted on slides with mounting medium containing 4,6-diamidino-2-phenylindole (DAPI, Vectashield). Samples were analysed using a Nikon confocal microscope.

![Sensitivity of *ctip* mutant cells to DNA damaging agents\
Clonogenic survival assays with asynchronous cell populations after exposure to X-rays (upper panel), cisplatin (CDDP, middle panel) and ultraviolet light (UV, lower panel). In this and the following figures, the data presented with error bars are the mean of three independent experiments, and the error bar indicates one standard deviation.](ukmss-4240-f0001){#F1}

![*ctip* mutant cells are sensitive to X-rays in both G1 and S/G2 phases of the cell cycle\
(a) Clonogenic colony survival assay after exposure of cell lines to X-rays, synchronised by elutriation in either S/G2 (upper panel) or G1 (lower panel) stages of the cell cycle. Data represent three independent experiments. (b) Western-blot showing the presence of CtIP in G1 and S/G2. Phosphorylated CtIP is indicated with an arrow. Only unphosphorylated CtIP (\*) is seen in G1. Whole cell extracts were prepared from elutriated cell poulations. Where indicated, S/G2 cell extract were treated with λ phosphatase for 2 h at 30°C. Western blot with antibody against actin was used as protein loading control.](ukmss-4240-f0002){#F2}

![*ctip* mutant cells are defective for homologous recombination and microhomology-mediated end joining (MMEJ)\
Repair is indicated by percentage of cells expressing GFP as described in [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}. Repair by (a) homologous recombination (HR); (b) single-strand annealing (SSA); (c) accurate non-homologous end-joining (accurate EJ); (d) microhomology-mediated end joining (MMEJ); (e) analysis of DNA sequences at repaired break sites in wild-type and *ctip* mutant cells. Individual sequences (shown in [Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}) were classified according to the nature of their joints into "accurate EJ", "inaccurate EJ" and "MMEJ".](ukmss-4240-f0003){#F3}

![Phosphorylation of S327 is required for generation of ssDNA in DT40 cells\
(a) Cells were labelled with 20 μM BrdU and treated with 8 Gy X-rays (where indicated). ssDNA was detected over time by staining with antibody against BrdU and analysed using confocal microscopy. Staining was performed under DNA denaturing (2N HCl) or native conditions as indicated. (b) Kinetics of ssDNA generation from (a). Cells containing 10 or more foci were scored as positive. (c) HR assay, performed as in [Fig. 3](#F3){ref-type="fig"} with indicated cell lines. Shows that expression of "constitutively activated" CtIPPM restores HR in ctip mutant cells but not in brca1 cells.](ukmss-4240-f0004){#F4}
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